Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

MLA

Hildesheim A, et al. “Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine among Young Women with Preexisting Infection: A Randomized Trial.” JAMA: Journal of the American Medical Association, vol. 298, no. 7, Aug. 2007, pp. 743–53. EBSCOhost, https://doi.org/10.1001/jama.298.7.743.

APA

Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, Gonzalez P, Dubin G, Porras C, Jimenez SE, Lowy DR, Costa Rican HPV (Human Papillomavirus) Vaccine Trial Group, Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., & Schiller, J. T. (2007). Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA: Journal of the American Medical Association, 298(7), 743–753. https://doi.org/10.1001/jama.298.7.743

Chicago

Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, et al. 2007. “Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine among Young Women with Preexisting Infection: A Randomized Trial.” JAMA: Journal of the American Medical Association 298 (7): 743–53. doi:10.1001/jama.298.7.743.